Oxytocin Nasal Spray

Oxytocin is a synthetic nonapeptide analogue of the endogenous hypothalamic neuropeptide, studied in non-human research models in relation to oxytocin receptor (OXTR) signaling, hypothalamic-pituitary axis neuropeptide activity, and social behavior pathway research. Scientific literature examines this compound in the context of OXTR-mediated signaling cascades, neuroendocrine axis modulation, and neuropeptide behavior across central and peripheral receptor distribution in controlled non-human research environments.

Research applications commonly explored in the literature include:

Oxytocin receptor (OXTR) binding selectivity and downstream signaling cascade investigation in non-human models

Hypothalamic neuropeptide axis activity and neuroendocrine signaling pathway research

Social behavior pathway and prosocial signaling modeling in non-human research frameworks

Comparative central versus peripheral oxytocin receptor distribution and signaling behavior studies

Neuropeptide bioavailability and intranasal delivery route investigation in CNS-focused research models

The nasal spray format supports investigation of intranasal delivery as an administration route for hypothalamic neuropeptides in non-human research models, enabling comparative analysis of peptide bioavailability and central OXTR accessibility across delivery methods. Each bottle of Oxytocin Nasal Spray is independently verified by third-party laboratories for molecular identity, purity, and concentration consistency.

1. What is Oxytocin studied for in research settings? Oxytocin appears in scientific literature in relation to OXTR receptor signaling, hypothalamic-pituitary neuropeptide axis activity, and social behavior pathway research. Studies investigate its role within neuroendocrine signaling frameworks and central versus peripheral receptor distribution modeling in non-human systems.
2. Why is Oxytocin studied in nasal spray format? Intranasal delivery supports comparative investigation of administration route effects on neuropeptide bioavailability and central OXTR receptor accessibility in non-human research models. Scientific literature examines whether intranasal delivery influences neuropeptide distribution across central and peripheral receptor populations compared to alternative administration routes.
3. How long does the spray remain viable after opening? Store in a refrigerator at 2–8°C and use within 30 days of first use to maintain sterility and compound integrity.
4. Is Oxytocin approved for any use in humans or animals? No. This product is not approved for human or veterinary use in the context in which KÖLD sells it. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.
5. How is purity and quality verified? Each bottle of Oxytocin Nasal Spray is independently verified by third-party laboratories for concentration accuracy, molecular identity, and sterility prior to release.

Before Opening

Store at 2–8°C (36–46°F)

Keep away from light and humidity

After Opening

Store at 2–8°C (36–46°F)

Use within 30 days

Keep upright and away from direct light